Ravi S Kane

28PUBLICATIONS
35CO-AUTHORS
NanomedicineMajor global burdens of diseaseMedical infection agents (incl. prions)Innate immunityCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 19, 2026
Characterization of Immune Responses to RBD-SD1 Nanoparticle Vaccines Derived From ACE2-Capable HKU5-CoV-2, NeoCoV, and HKU5 Merbecoviruses.

|Jun 15, 2026
Characterization and immunogenicity of nanoparticle vaccines displaying embecovirus spike proteins.

|Feb 25, 2026
RBD-SD1 Nanoparticle Vaccines From DPP4-Using Merbecoviruses Elicit a Cross-Reactive Antibody Response but Limited Cross-Protective Immunity.

Peter J Halfmann, Jeong Soo Lee, Tong Wang

|Dec 08, 2025
Hemagglutinin-displaying influenza nanovaccines: progress and promise.

Donguk Kim, Augustine Duffy, Alex Wee

|Sep 29, 2025
Tethered Antigenic Suppression Shields the Hemagglutinin Head Domain and Refocuses the Antibody Response to the Stalk Domain.

Donguk Kim, Kathryn Loeffler, Yixin Hu

|Apr 29, 2025
Facile generation of drug-like conformational antibodies specific for amyloid fibrils.

Alec A Desai, Jennifer M Zupancic, Hanna Trzeciakiewicz

Pageof 5

Frequent Collaborators

5 joint publications

Yoshihiro Kawaoka

3 joint publications

Nikki McArthur

3 joint publications

Peter J Halfmann

3 joint publications

Jie E Yang